VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
BCPC
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
BCPCBalchem Corp
$168.40$5.4B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksBCPCBalance Sheet

Balchem Corp (BCPC) Balance Sheet

30Y historyFree accessUpdated daily

Balchem's balance sheet is fortress-like, with debt-to-equity at 0.13 and total debt down to $166.7M from $321.5M in 2024Q1, while current ratio stands at 2.66.

Income StatementBalance SheetCash FlowRatios

BCPC Balance Sheet

Annual statement

BCPC Balance Sheet

Balchem Corp (BCPC) balance sheet — 30-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Total Current Assets388.42M365.61M313.77M314.24M335.8M322.23M266.89M254.95M226.31M199.34M188.44M198.83M181.3M277.77M211.91M175.74M129.65M93.01M55.25M52.47M28.86M35.27M29.21M23.63M18.81M17.02M11.37M9.1M8.4M7.3M5.6M
Cash & Short-Term Investments63.17M74.57M49.52M64.45M66.56M103.24M84.57M65.67M54.27M40.42M38.64M84.8M50.29M208.75M144.74M114.78M77.25M46.43M3.42M2.31M5.19M13M12.73M9.24M1.73M3.12M3.07M1.7M1.3M700K100K
Cash Only63.17M74.57M49.52M64.45M66.56M103.24M84.57M65.67M54.27M40.42M38.64M84.8M50.29M208.75M144.74M114.78M77.25M46.43M3.42M2.31M5.19M13M12.73M9.24M1.73M3.12M3.07M1.7M1.3M700K100K
Short-Term Investments0000000000000000000000000000000
Accounts Receivable148.97M143.6M119.66M125.28M131.58M117.41M98.21M93.44M99.55M91.23M83.25M60.48M71.98M39.39M42M34.43M32.05M29.15M30.25M29.64M11.58M11.52M8M7.23M7.16M7.13M5.04M4M3.3M3.1M3M
Days Sales Outstanding48.650.5345.849.5750.9653.6350.9552.9956.4555.9854.9339.9648.5342.6449.3943.0645.8648.4847.5861.441.885.0143.342.6743.4156.455.4649.1641.9739.5641.48
Inventory161.55M131.45M130.8M109.52M119.67M91.06M70.62M83.89M67.19M60.7M57.24M46.09M49.62M24.82M20.69M18.64M15.72M13.96M16.62M15.68M9.92M8.54M6.32M5.96M7.24M5.58M2.55M2.7M2.9M2.5M1.9M
Days Inventory Outstanding75.4871.9877.3264.4465.9959.7953.7370.8355.8154.656.1243.7645.637.7934.233.0432.4133.4333.844.2754.1157.2852.953.4371.6272.1254.3863.1767.8559.6450.62
Other Current Assets5.33M6.22M5.74M7.19M13.09M4.41M3.44M7.55M1.48M2.22M5.19M3.72M4.87M2.24M1.11M954K1.1M1.42M2.38M2.39M416K276K321K474K403K214K200K700K900K1M600K
Total Non-Current Assets1.3B1.34B1.26B1.28B1.29B877.09M898.96M900.74M755.04M764.3M760.18M682.39M679.97M99.1M100.64M95.98M98.97M94.8M99.22M101.95M63.48M39.88M31.19M33.28M34.49M27.45M11.85M12.9M14.2M10.3M9.5M
Property, Plant & Equipment318.82M322.84M299.2M295.9M290.79M246.81M236.51M224.2M194.34M189.79M165.75M158.51M131.59M54.92M52.73M44.28M43.39M41.58M42.51M42.08M31.31M24.4M24.19M25.64M25.85M17.9M7.76M7.8M8.1M7.3M7.5M
Fixed Asset Turnover3.41x3.21x3.19x3.12x3.24x3.24x2.98x2.87x3.31x3.13x3.34x3.49x4.11x6.14x5.89x6.59x5.88x5.28x5.46x4.19x3.22x34.39x2.79x2.41x2.33x2.58x4.28x3.81x3.54x3.92x3.52x
Goodwill808.81M816.38M780.03M778.91M769.51M523.95M529.46M524M448M441.36M439.81M383.91M383.65M28.52M28.52M28.52M28.52M26.66M26.66M26.36M25.25M13.33M6.37M6.37M6.4M000000
Intangible Assets151.64M163.29M165.05M191.21M213.29M94.67M121.66M143.92M105.98M128.07M147.48M134.91M160.39M15.13M18.86M22.71M26.65M26.5M29.99M33.45M6.91M2.15M637K1.27M2.24M9.55M4.09M5.1M6.1M2.9M2M
Long-Term Investments14.55M3.72M3.86M4.08M4.29M-46.45M-51.36M-56.43M4.9M4.8M4.55M-810K-1.39M-893K-47.97M-556K-552K-891K0-515K00000000000
Other Non-Current Assets15.74M14.42M13.46M12.87M-51.96M11.67M11.33M8.62M-42.49M-48.28M1.87M5.06M4.34M541K47.91M474K420K60K59K61K000000000100K0
Total Assets1.69B1.71B1.58B1.6B1.62B1.2B1.17B1.16B981.36M963.64M948.63M881.22M861.27M376.87M312.55M271.72M228.62M187.81M154.47M154.42M92.33M75.14M60.41M56.91M53.3M44.48M23.22M22M22.6M17.6M15.1M
Asset Turnover0.64x0.61x0.61x0.58x0.58x0.67x0.60x0.56x0.66x0.62x0.58x0.63x0.63x0.89x0.99x1.07x1.12x1.17x1.50x1.14x1.09x11.17x1.12x1.09x1.13x1.04x1.43x1.35x1.27x1.63x1.75x
Asset Growth %17.64%8.39%-1.37%-1.68%35.45%2.87%0.88%17.76%1.84%1.58%7.65%2.32%128.53%20.58%15.03%18.85%21.73%21.58%0.03%67.25%22.88%24.4%6.15%6.77%19.83%91.53%5.55%-2.65%28.41%16.56%5.59%
Total Current Liabilities145.75M176.38M157.69M148.49M140.04M143.8M94.43M92.26M82.06M108.4M101.01M81.12M95.52M35.75M30.23M30.91M29.51M33.81M25.68M36.33M9.56M9.15M5.71M6.08M7.93M6.48M3.28M2.8M3.5M3.6M3.5M
Accounts Payable70.45M60.42M54.74M55.5M57.32M56.24M23.74M37.27M33.79M28.45M32.51M14.71M24.35M12.39M14.28M11.53M9.76M10.88M10.34M11.19M3.01M2.56M1.47M1.25M2.78M2.88M970K600K1.1M2.7M2.5M
Days Payables Outstanding32.7933.0932.3632.6631.6136.9318.0631.4628.0725.5931.8713.9722.3818.8723.5920.4420.1126.0321.0231.616.4217.1912.2711.2427.4937.3220.6514.0425.7464.4166.61
Short-Term Debt3.38M3.82M000000035M35M35M35M001.39M1.48M6.78M4.9M10.59M0001.74M1.74M1.75M0600K1.2M800K700K
Deferred Revenue (Current)00000000000000040K00042K00000000000
Other Current Liabilities51.96M77.18M22.89M17.23M16.54M19.57M48.6M41.46M2.26M13.85M12.09M13.46M11.42M7.86M4.14M4.29M13.56M005.83M4.68M4.83M2.75M389K382K305K521K1.6M1.2M100K300K
Current Ratio2.66x2.07x1.99x2.12x2.40x2.24x2.83x2.76x2.76x1.84x1.87x2.45x1.90x7.77x7.01x5.68x4.39x2.75x2.15x1.44x3.02x3.85x5.12x3.89x2.37x2.63x3.47x3.25x2.40x2.03x1.60x
Quick Ratio1.56x1.33x1.16x1.38x1.54x1.61x2.08x1.85x1.94x1.28x1.30x1.88x1.38x7.07x6.32x5.08x3.86x2.34x1.50x1.01x1.98x2.92x4.01x2.91x1.46x1.77x2.69x2.29x1.57x1.33x1.06x
Cash Conversion Cycle91.2989.4390.7681.3585.3476.4986.6192.3584.1984.9979.1769.7571.7561.5659.9955.6758.1655.8860.3674.0879.5745.1183.9384.8687.5491.289.1898.2984.0834.7925.49
Total Non-Current Liabilities238.87M273.76M267.77M394.74M546.19M178.51M243.18M319.76M207.68M238.36M326.58M336.4M373.85M9.76M9.3M8.79M11.65M6.86M14.28M25.01M7.41M5.06M4.46M11.05M12.1M12.67M362K1.3M3.3M1.7M2.2M
Long-Term Debt152M175.32M190M309.57M440.57M108.57M163.57M248.57M156M183.96M245.49M260.96M297.5M03.43M23K3.43M06.67M17.4M0007.84M9.58M11.32M0700K2.6M800K1.4M
Capital Lease Obligations50.12M12.87M14.72M16.54M16.02M7.11M6.08M4.83M00000000000000000000000
Deferred Tax Liabilities229.37M75.45M43.72M52.05M62.78M46.45M51.36M56.43M44.31M48.55M74.2M67.22M70.4M5.88M5.87M5.98M5.64M5.03M6M6.09M6.63M4.01M3.46M2.23M1.56M351K225K400K500K500K500K
Other Non-Current Liabilities22.59M10.12M19.34M16.58M26.81M16.37M22.18M9.93M7.37M5.85M6.9M6.68M5.95M3.88M02.79M2.58M1.82M1.61M1.53M784K1.04M1M985K964K994K137K200K200K400K300K
Total Liabilities384.63M450.15M425.46M543.23M686.23M322.31M337.61M412.01M289.74M346.75M427.59M417.52M469.37M45.51M39.53M39.71M41.16M40.67M39.97M61.34M16.97M14.21M10.17M17.13M20.03M19.14M3.64M4.1M6.8M5.3M5.7M
Total Debt166.72M192.01M208.04M330.33M460.61M118.04M171.99M255.87M156M218.96M280.49M295.96M332.5M3.88M3.43M1.41M4.91M6.78M11.57M27.99M0009.58M11.32M13.07M01.3M3.8M1.6M2.1M
Net Debt103.54M117.44M158.53M265.89M394.05M14.8M87.41M190.2M101.73M178.55M241.85M211.17M282.21M-204.87M-141.31M-113.37M-72.34M-39.65M8.15M25.68M-5.19M-13M-12.73M342K9.59M9.95M-3.07M-400K2.5M900K2M
Debt / Equity0.13x0.15x0.18x0.31x0.49x0.13x0.21x0.34x0.23x0.35x0.54x0.64x0.85x0.01x0.01x0.01x0.03x0.05x0.10x0.30x---0.24x0.34x0.52x-0.07x0.24x0.13x0.22x
Debt / EBITDA0.58x0.73x0.90x1.54x2.34x0.67x1.06x1.72x1.03x1.55x2.05x2.21x2.95x0.05x0.05x0.02x0.08x0.14x0.31x0.87x---0.76x0.75x1.21x-0.19x0.58x0.30x0.47x
Net Debt / EBITDA0.36x0.45x0.69x1.24x2.00x0.08x0.54x1.28x0.67x1.26x1.76x1.58x2.50x-2.69x-2.04x-1.73x-1.24x-0.81x0.22x0.80x-0.23x-0.66x-0.79x0.03x0.64x0.92x-0.39x-0.06x0.38x0.17x0.44x
Interest Coverage24.31x20.48x11.07x7.07x14.03x51.99x24.97x17.19x14.01x12.73x12.41x14.21x15.98x2743.42x5985.40x676.45x558.01x195.27x30.52x------------
Total Equity1.3B1.26B1.15B1.05B938.28M877.01M828.23M743.67M691.62M616.88M521.03M463.7M391.9M331.36M273.01M232.01M187.47M147.14M114.51M93.08M75.36M60.93M50.23M39.78M33.27M25.33M19.58M17.9M15.8M12.3M9.4M
Equity Growth %28.64%9.35%9.1%12.33%6.99%5.89%11.37%7.53%12.12%18.4%12.36%18.32%18.27%21.37%17.67%23.76%27.4%28.5%23.02%23.51%23.68%21.3%26.28%19.57%31.33%29.38%9.39%13.29%28.46%30.85%27.03%
Book Value per Share40.3938.5735.1532.4828.9726.8425.4822.8821.3219.1416.3214.6612.5710.748.997.676.335.104.013.352.742.261.921.571.331.030.810.720.620.500.40
Total Shareholders' Equity1.3B1.26B1.15B1.05B938.28M877.01M828.23M743.67M691.62M616.88M521.03M463.7M391.9M331.36M273.01M232.01M187.47M147.14M114.51M93.08M75.36M60.93M50.23M39.78M33.27M25.33M19.58M17.9M15.8M12.3M9.4M
Common Stock2.13M2.14M2.17M2.15M2.15M2.15M2.16M2.16M2.15M2.13M2.12M2.1M2.06M2.02M1.96M1.94M1.92M1.87M823K804K788K776K508K327K327K327K327K300K000
Retained Earnings1.21B1.12B997.49M897.49M814.49M732.14M656.74M590.92M528.03M464.64M388.09M344.2M295.2M251.63M214.61M181.07M147.54M118.58M94.88M77.84M63.99M53.31M43.4M36.06M30.81M23.77M18.97M15.5M12.7M9.9M7.3M
Treasury Stock000000-7.87M-18.07M-56K00-74K000000000-1.16M0-504K-1.41M-2.15M-2.8M-900K000
Accumulated OCI27.21M41.55M-23.75M8.69M-7.15M-4.99M4.17M-5.56M-3.6M-1.64M-6.85M-5.11M-2.65M198K-759K-938K-549K153K-8K150K193K-17.93M-15.35M-12.82M-11.02M-9.19M-7.86M-7M-6M-5.2M-7.2M
Minority Interest0000000000000000000000000000000

Key Metrics

Growth RegimeAccelerating
ProfitabilityStable
Balance SheetFortress
Cash FlowRobust
Top Statement Risk

Ethylene oxide regulatory risk

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

Leverage Declines as Assets Expand

Balchem's total assets grew to $1.7B by 2026Q2, while total debt fell from $321.5M in 2024Q1 to $166.7M, per reported figures, indicating a strengthening balance sheet.

The sequential reduction in debt, from $321.5M to $166.7M over ten quarters, alongside stable asset growth, suggests a deliberate deleveraging trend. This appears to be driven by strong cash generation, as cumulative operating cash flow exceeded net income, per prior analysis. The balance sheet trajectory implies enhanced financial flexibility, which may support future strategic moves without straining liquidity.

Minimal Leverage Provides Strategic Cushion

Debt-to-equity fell to 0.13 in 2026Q2 from 0.30 in 2024Q1, as per financial statements, reflecting a conservative capital structure that insulates Balchem from rising rates.

Total debt of $166.7M against equity of $1.3B yields a D/E ratio of 0.13, which is exceptionally low compared to peers like Ingredion (0.41) and Avient (0.81). This suggests that leverage is not a necessity but a strategic choice, likely to preserve flexibility. The absence of refinancing risk is notable, as the company's cash position of $63.2M covers a significant portion of its debt, though the maturity profile is not disclosed.

Intangible-Heavy Asset Base Signals M&A

Goodwill of $808.8M represents nearly half of total assets, per reported data, indicating a history of acquisitions that may pose impairment risk if growth stalls.

Goodwill and intangibles dominate the asset mix, with goodwill alone at $808.8M versus PPE of $318.8M. This suggests an asset-light operational model reliant on acquired intellectual property, consistent with the company's microencapsulation moat. The steady increase in goodwill from $771.5M in 2024Q1 to $808.8M indicates continued tuck-in acquisitions. Investors should monitor whether organic growth justifies these carrying values, as any sustained underperformance could trigger impairment charges.

Retained Earnings Drive Equity Growth

Retained earnings rose to $1.2B in 2026Q2 from $926.5M in 2024Q1, per reported figures, reflecting strong profit retention and a conservative payout policy.

Equity expanded to $1.3B, primarily fueled by retained earnings, which grew by over $250M in ten quarters. This indicates that management is reinvesting profits into the business rather than distributing them, consistent with the low dividend and moderate buyback activity. The quality of equity is high, as it is built on cumulative earnings rather than financial engineering, though stock-based compensation of ~$4.8M per quarter, per prior analysis, does dilute shareholders modestly.

Liquidity Buffer Remains Robust

Current ratio improved to 2.66 in 2026Q2 from 2.61 in 2024Q1, per reported data, while cash of $63.2M provides a solid cushion against short-term obligations.

With a current ratio above 2.5 consistently, Balchem maintains a strong liquidity position, well above the 1.0 threshold. Cash balances have fluctuated but remain adequate relative to total liabilities of $384.6M. The company's ability to cover short-term obligations without relying on external financing is a key strength, especially given the low debt levels. This liquidity buffer appears sufficient to absorb operational shocks, though the recent EPS miss suggests monitoring cash conversion efficiency.

Goodwill Impairment Risk Lurks

Goodwill of $808.8M, per reported figures, constitutes a significant portion of assets, and any acquisition-related underperformance could lead to impairment charges that erode equity.

The balance sheet's headline strength masks the concentration of intangible assets, which are subject to impairment testing. If the HNH or ANH segments fail to meet growth expectations, the company may need to write down goodwill, directly impacting equity. Additionally, the absence of deferred revenue suggests limited forward visibility from customer prepayments, which may indicate that revenue recognition is tied to point-in-time deliveries rather than long-term contracts. This warrants scrutiny of the durability of the revenue stream.

BCPC — Frequently Asked Questions

Quick answers to the most common questions about buying BCPC stock.

What are the total assets of Balchem Corp (BCPC)?

As of 2025, Balchem Corp (BCPC) had total assets of $1.71B including $365.6M in current assets.

How much debt does Balchem Corp (BCPC) have?

Balchem Corp (BCPC) carries total debt of $192.0M, offset by $74.6M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Balchem Corp?

Balchem Corp (BCPC) has total shareholders' equity (book value) of $1.26B ($38.57 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Balchem Corp's current ratio and liquidity?

Balchem Corp (BCPC) reported a current ratio of 2.07x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.